Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach

Phoebe Tsz Man Cheng, BSc,MD, Diego Villa, MD MPH, R. Petter Tonseth, MD, David W. Scott, MBChB, PhD, Alina S Gerrie, MD MPH, Ciara L Freeman, MSc, MBBChir, Christina Aquino Parsons, MD, Tom Pickles, MD, Andrea Lo, MD, Don Wilson, MD, Brian Skinnider, MD, Laurie H Sehn, MD, Joseph M Connors, MD, Kerry J Savage, BSc, MD MSc

Blood (2019) 134 (Supplement_1): 2845.

https://doi.org/10.1182/blood-2019-122019

Published: 2019

Journal Articles

Molecular Correlates of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma

Robert Kridel, MDMPH,PhD, Keren Isaev, MSc, Daisuke Ennishi, MD PhD, Brian Skinnider, MD, Karen Mungall, PhD, Andrew J. Mungall, PhD, Mehran Bakhtiari, MSc, Rosemarie Tremblay-Lemay, MD MSc, FRCPC, Barbara Meissner, PhD, Susana Ben-Neriah, BSc, Merrill Boyle, BSc, Diego Villa, MD MPH, Marco A. Marra, PhD, Christian Steidl, MD, Randy D. Gascoyne, MD, Kerry J Savage, BSc, MD MSc, David W. Scott, MBChB, PhD

Blood (2019) 134 (Supplement_1): 2763.

https://doi.org/10.1182/blood-2019-124235

Published: 2019

Journal Articles

Outcomes In Splenic Marginal Zone Lymphoma: Analysis Of 108 Patients Treated In British Columbia (BC)

Katharine He Xing, MD, Amrit Kahlon, MD, Joseph M. Connors, MD, Brian Skinnider, MD, Randy D. Gascoyne, MD, Laurie H. Sehn, MD, MPH, Kerry J. Savage, MD, MSc, Graham W. Slack, MD, Tamara Shenkier, MD, Richard Klasa, MD, Alina S. Gerrie, MD, Diego Villa, MD, MPH

Blood (2013) 122 (21): 4369.

https://doi.org/10.1182/blood.V122.21.4369.4369

Published: 2013

Journal Articles

Impact of Time from Diagnosis to Initiation of Curative-Intent Chemotherapy on Clinical Outcomes in Patients with Hodgkin Lymphoma

Edward G. Brooks, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD, Randy D. Gascoyne, MD, Kerry J. Savage, MD, MSc, Tamara Shenkier, MD, Richard Klasa, MD, Alina S. Gerrie, MD, Brian Skinnider, MD, Graham Slack, MD, Diego Villa, MD, MPH

Blood (2013) 122 (21): 4237.

https://doi.org/10.1182/blood.V122.21.4237.4237

Published: 2013

Journal Articles

The Outcome of Advanced Stage Nodular Lymphocyte Predominant Hodgkin's Lymphoma (NLPHL) Compared to Classical Hodgkin's Lymphoma (CHL): A Matched Pair Analysis

Katharine He Xing, MD, Joseph M. Connors, MD, Mubarak Al-Mansour, MD, Randy D. Gascoyne, MD, Brian Skinnider, MD, Kerry J. Savage, MD MSc

Blood (2012) 120 (21): 1531.

https://doi.org/10.1182/blood.V120.21.1531.1531

Published: 2012

Journal Articles

Incorporation of ABVD Increases Cure Rates of Patients with Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)

Kerry Joanne Savage, MD, MSc, Brian Skinnider, MD, Mubarak Al Mansour, MD, Laurie H Sehn, MD, MPH, Randy D. Gascoyne, MD, Joseph M. Connors, MD

Blood (2010) 116 (21): 3887.

https://doi.org/10.1182/blood.V116.21.3887.3887

Published: 2010

Journal Articles

Follicular Non-Hodgkin Lymphoma Grade 3a and 3b Subtypes Exhibit Similar Clinical Behaviour and Treatment Outcome

Jesse Shustik, MD, Michael Quinn, MD, Joseph M Connors, MD, Randy D Gascoyne, MD, Brian Skinnider, MD, Laurie H Sehn, MD, MPH

Blood (2008) 112 (11): 3777.

https://doi.org/10.1182/blood.V112.11.3777.3777

Published: 2008

Journal Articles

Strong p53 Expression Is an Independent Predictor of Outcome in De Novo Diffuse Large B Cell Lymphoma (DLBCL) Treated with Either CHOP or CHOP-R.

Pedro Farinha, MD, Laurie Sehn, MD, Brian Skinnider, MD, Lin Wu, Nancy Patten, Sim Truong, Joseph M. Connors, MD, Randy D. Gascoyne, MD

Blood (2006) 108 (11): 812.

https://doi.org/10.1182/blood.V108.11.812.812

Published: 2006

Journal Articles

Addition of Rituximab (R) to CHOP Improves Survival in the Non-GCB Subtype of Diffuse Large B Cell Lymphoma (DLBCL).

Pedro Farinha, MD, Laurie Sehn, MD, Brian Skinnider, MD, Joseph M. Connors, MD, Randy D. Gascoyne, MD

Blood (2006) 108 (11): 816.

https://doi.org/10.1182/blood.V108.11.816.816

Published: 2006

NARROW

Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach

Molecular Correlates of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma

Outcomes In Splenic Marginal Zone Lymphoma: Analysis Of 108 Patients Treated In British Columbia (BC)

Impact of Time from Diagnosis to Initiation of Curative-Intent Chemotherapy on Clinical Outcomes in Patients with Hodgkin Lymphoma

The Outcome of Advanced Stage Nodular Lymphocyte Predominant Hodgkin's Lymphoma (NLPHL) Compared to Classical Hodgkin's Lymphoma (CHL): A Matched Pair Analysis

Incorporation of ABVD Increases Cure Rates of Patients with Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)

Follicular Non-Hodgkin Lymphoma Grade 3a and 3b Subtypes Exhibit Similar Clinical Behaviour and Treatment Outcome

Strong p53 Expression Is an Independent Predictor of Outcome in De Novo Diffuse Large B Cell Lymphoma (DLBCL) Treated with Either CHOP or CHOP-R.

Addition of Rituximab (R) to CHOP Improves Survival in the Non-GCB Subtype of Diffuse Large B Cell Lymphoma (DLBCL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only